Cansortium (OTCMKTS:CNTMF) Issues Earnings Results

Cansortium (OTCMKTS:CNTMF) issued its earnings results on Thursday. The company reported ($0.16) EPS for the quarter, RTT News reports. During the same period in the prior year, the firm posted ($0.14) EPS.

Cansortium Price Performance

OTCMKTS:CNTMF traded down $0.01 during trading hours on Thursday, reaching $0.03. The company’s stock had a trading volume of 1,976,310 shares, compared to its average volume of 327,199. The firm has a 50-day simple moving average of $0.03 and a 200-day simple moving average of $0.04. Cansortium has a 1 year low of $0.03 and a 1 year high of $0.09.

Cansortium Company Profile

Cansortium, Inc (OTCMKTS:CNTMF) is a vertically integrated cannabis company engaged in the cultivation, manufacturing, distribution and retail of medical cannabis products in the United States. The company’s operations span from seed to sale, with dedicated cultivation facilities, extraction labs and a network of dispensaries serving registered patients.

Cansortium holds licenses and operates in multiple jurisdictions, including Florida, Pennsylvania, Louisiana, Texas and Puerto Rico. Its product portfolio encompasses cannabis flower, pre-rolls, concentrates, vape cartridges, oils, edibles and topicals, offered under brands such as The+Source, Chroma and Campfire, alongside its private-label formulations.

Founded in 2017 and headquartered in Miami, Cansortium began dispensary operations in Florida in 2018 and has since expanded its footprint into new markets.